In light of these findings, we can conclude that our study unveiled a parallel clinical connection between elevated Metrnl levels, visceral obesity, insulin resistance, hyperinsulinemia, and the proinflammatory factor IL-18. The gene discussed is IL18; the disease is Hyperinsulinemia.